article thumbnail

3rd time's the charm: AbbVie scores FDA nod for continuous Parkinson's disease therapy Vyalev

Fierce Pharma

AbbVie made history in 2015 with its Parkinson’s disease infusion pump therapy Duopa, kicking off a trend of delivery system innovation in the space as drugmakers sought to avoid the common pitfall | The 24-hour Parkinson's disease therapy crossed the FDA finish line after an initial manufacturing-related rejection last year and another snub in (..)

FDA 315
article thumbnail

Pfizer settles gender pay discrimination allegations at NYC headquarters

Fierce Pharma

The accusations centered on the company's compensation of 86 female employees in 2015 and 2016. Department of Labor that it underpaid certain women who were employed at the company’s New York City headquarters. |

315
315
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

At JPM, Top GSK Cancer Executive Talks Drug Targets and Oncology Strategy

MedCity News

Though GSK divested much of its oncology assets to Novartis in 2015, the company has built it back through a internal R&D and business development deals. GSK Senior Vice President, Global Head of Oncology, R&D Hesham Abdullah explained the company’s evolving cancer strategy in an interview during the J.P.

article thumbnail

How high-intent platforms help pharma brands engage action-oriented customers

Fierce Pharma

Way back in 2015 a post on the Think with Google blog made the bold claim that, for marketers, consumer intent is more powerful than demographics: “Intent beats identity. GoodRx is a trusted, high-intent platform that helps providers and patients find what they need at the exact moment they are looking for something.

Pharma 263
article thumbnail

Labor Department Sues UnitedHealth Group Over ‘Thousands’ of Claims Denials

MedCity News

The Labor Department recently sued UnitedHealth Group subsidiary UMR, alleging that it wrongfully denied claims for emergency room services and urinary drug screenings since 2015.

Medical 246
article thumbnail

The financial toxicity of treating cancer

World of DTC Marketing

billion in 2015 and $208.9 Newly approved cancer drugs cost an average of $10,000 per month, with some as high as $30,000 per month. Just over a decade ago, the standard was $4,500. National costs for cancer care were estimated to be $190.2 billion in 2020 (2020 U.S. population.

Insurance 325
article thumbnail

Our healthcare system is really screwed up

World of DTC Marketing

A 2015 Commonwealth Fund brie f showed that — before the major provisions of the Affordable Care Act were introduced — the United States had worse outcomes and spent more on health care, primarily because of greater use of medical technology and higher prices, compared to other high-income countries.